Drugdiscovery >> Clinical Trials >> News
3588
Views
Experimental durg of  Pfizer gives promising results in prevention of community acquired pneumonia - drugdiscovery.com
Experimental durg of Pfizer gives promising results in prevention of community acquired pneumonia - drugdiscovery.com


Pfizer has just finished its landmark stuy over a pnemonia drug. The trial which is based on over 85,000 samples and the new treatment seems to be very effective on patient 65 years and over.
Read More >>


Tags: drug; discovery, development, news, Pfizer, CAPITA, clinical trial, CAP, pneumonia, primary endpoint - March 13, 2014
Related Articles
5994
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

7450
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

3480
Views
Incyte's new drug produced promising results for Polycythemia Vera Incyte's new drug produced promising results for Polycythemia Vera
Incyte's Polycythemia Vera drug produced far better results on clinical Phase III trials than the former alternatives of medicine for patients who are resistant to or intolerant of hydroxyurea. Read More >>

Tags: hydroxyurea, Incyte, Polycythemia Vera

4903
Views
Theravance’s experimental COPD drug meets study goal Theravance’s experimental COPD drug meets study goal
Theravance announced that the drug, named TD-408, taken as a once-per-day treatment for moderate to severe chronic obstructive pulmonary disease met its goals in a midstage clinical trial. Read More >>

Tags: Theravance, experimental drug, COPD, lung disease, clinical trial

8152
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

21001
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

3696
Views
Prevention of Alzheimer’s: the first clinical trial begins Prevention of Alzheimer’s: the first clinical trial begins
The first clinical trial, which will test whether giving new drug treatments before dementia can prevent Alzheimer’s, has been launched. Read More >>

Tags: Alzheimer’s, prevention, clinical trial

5276
Views
Teplizumab effective in phase 2 Teplizumab effective in phase 2
Teplizumab is an experimental drug designed to block the advance of type 1 diabetes in its earliest stages. It showed success in phase II clinical trial in patients who still had moderately healthy Read More >>

Tags: Teplizumab,experimental drug, clinical trial, type 1 diabetes, insulin, immunotherapy

7208
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

4728
Views
Ventrus’ drug for anal fissures shows positive clinical results Ventrus’ drug for anal fissures shows positive clinical results
Diltiazem hydrochloride 2% cream (VEN 307) has been successful in two clinical dermal safety studies and one pharmacokinetic (PK) study. This paves way to new drug application (NDA) for VEN 307 as a t Read More >>

Tags: Ventrus, VEN 307, anal fissures, cream, new treatment, clinical trials

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013